Najla El Jurdy

18PUBLICATIONS
110CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 20, 2026
Identification of Microbiome Associations with Tacrolimus Pharmacokinetics in Adult Hematopoietic Cell Transplantation Using Population Pharmacokinetic and Machine Learning.

|Jun 12, 2026
Attenuation of Immune Senescence Markers After Intensive Cancer Therapy Through Resistance Training: A Pilot Study.

|Apr 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

|Jul 01, 2025
Diagnostic approaches for haematopoietic cell transplantation-associated membranous nephropathy: Novel underutilized tools.

Najla El Jurdi, Meryl A Waldman, Eduard Schulz

|May 05, 2025
A phase 2 study of single agent ibrutinib for first-line treatment of chronic graft-versus-host disease: A new paradigm and lessons learned.

Najla El Jurdi, Noa G Holtzman, Rania Hishmeh

|Apr 30, 2025
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.

Sameem Abedin, Michael J Martens, Javier Bolaños-Meade

Pageof 3

Frequent Collaborators

10 joint publications

Daniel Weisdorf

6 joint publications

Shernan Holtan

3 joint publications

Claudio G Brunstein

3 joint publications

Joseph Maakaron